Senior GxP IT Applications Lead – Lab & Manufacturing

Sun Pharmaceutical Industries Ltd; Billerica (MA); Presencial; USD 105.000 - 129.000; Jornada completa

Descripción de la vacante

Sun Pharmaceuticals seeks a Sr. Associate, GxP IT Applications Administrator to manage day-to-day administration, user support and validation of GxP computer systems in QC Analytical Lab, Manufacturing and other regulatory functions across North America.

This role requires coordinating with global teams, maintaining GxP systems inventory, and guiding end-to-end lifecycle management including validation, deployment, maintenance and audits. Travel up to 25-30% is expected.

Formación

• Bachelor's degree required; preference for Life Sciences, Pharmacy, CS, CIS or related field.
• Strong understanding of GAMP 5, 21 CFR Part 11, Computer System Validation, and Quality Management System.
• Excellent collaboration and communication skills; ability to manage competing priorities.

Responsabilidades

• Collaborate with global and regional stakeholders to implement and support GxP applications and systems in controlled environments.
• Maintain GxP Systems Inventory and manage end-to-end lifecycle: validation, deployment, maintenance, upgrades and retirement.
• Manage User Access lifecycle and periodic reviews; ensure backups and recovery of GxP systems.

Conocimientos

GxP Systems Admin

Documentation & Validation

Regulatory Compliance

Communication Skills

Problem Solving

Educación

Bachelor's Degree in Life Sciences/Pharmacy/CS

Herramientas

MS Office

Descripción del empleo

Sun Pharmaceuticals seeks a Sr. Associate, GxP IT Applications Administrator to manage day-to-day administration, user support and validation of GxP computer systems in QC Analytical Lab, Manufacturing and other regulatory functions across North America.

This role requires coordinating with global teams, maintaining GxP systems inventory, and guiding end-to-end lifecycle management including validation, deployment, maintenance and audits. Travel up to 25-30% is expected.